Tag | Content |
---|
EnhancerAtlas ID | HS098-19222 |
Organism | Homo sapiens |
Tissue/cell | HSMM |
Coordinate | chr15:48883690-48885740 |
SNPs | Number: 2 | ID | Chromosome | Position | Genome Version |
|
| Number of super-enhancer constituents: 6 | ID | Coordinate | Tissue/cell |
SE_37616 | chr15:48883228-48885970 | HSMMtube | SE_44183 | chr15:48882624-48886364 | NHDF-Ad | SE_45465 | chr15:48883886-48884652 | NHLF | SE_45465 | chr15:48884781-48885410 | NHLF | SE_45591 | chr15:48881980-48887497 | Osteoblasts | SE_63631 | chr15:48883437-48886063 | HSMM |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH15I048591 | chr15 | 48883449 | 48885811 |
|
Enhancer Sequence | GCACATTTAT ATGTCCTGTA AACACACAGG AATCTCTCTC TTTCCAAGAG CAGATTCGTA 60 CGTTGAAATC AATCAAATAG AGGAATATTC CAAAACCCTA CATTTGAAAC ATCCAAGAAT 120 ATGCAAGAAT CCTTTCTTTT GCCTTTTCAT CTTGACTTCC ATTCTAAGAT TCATAGTTCT 180 AGGTTTCTTC TTACCGTTCC TCAGAAAAGT CTTTAGAGTT ATGAGTGGCC CCTTTCCAGT 240 GAGGTCTTCA GAGTTACGAG TGGCCCCTTT CCAGTGAGGT CTTTAGAGTT ATGAGTGGCC 300 CCTTTCCAGT GAGGTCTTTA GAGTTACGAG TGGCCCCTTT CCAGTGAAGT CCAAGTACTA 360 CACAGTGGCT ATGTGCACAG GCTTAGGAGC CAGAATGTCT AGGTTCAGGC CTCTATTTTA 420 CCACTTATAA GCTGTCCCTT CTTGGACAAG GCACTTGATC TCTCTTTGCC TCTGCTTATT 480 CCTCCATAAG ATGGGACTTA TTACAGGACT TTTCTCATAA GGTTGTTGCA AATCATCAAA 540 GTGAAGTGCT TAGCACACCC CCTGGCACAC TGCAAGTACT CAGTACATGT CAGCTGTTCT 600 TACGTCCAAT GGCCGCTTTA TGATTCTCAT TCTCAGACCT TCGATGAGTC TAACAATTGC 660 CAAGTTATTT CTTGAACTCC TTTTTGTTTG TTTGGTTCAA TGCTCTCCTG GTTCTCTTGC 720 TGTATCTCTT TGTTTCTCTT CTTCCCTAAG CCTATTCATC ATCACACCCC ACCCCCATCT 780 CCAAGTTCAG GTCTATCTCC ATCATTCTTT TCTCTTTTGA CATGACCCTG AAAAGTCTCA 840 TCCACTCATA TGATTCACTG TGTTTAATAC AAAGGCATTT AACAAGATTT TAAATGTGCA 900 TTCTGAGGCA AGATGGCAAG AGAAAGGGAT TCCACACAGT TTTTTTGTTA GCAGTAACTA 960 TGGCAATATA CGACTAGCTT GTATTGTCAT TGCCAAAACA GGCACTGACC TCACTTCAAT 1020 AATCTGATAA CAAATGCTAA CATACTGTAC CACTGAGCTA AGAAGTGATT AAGTTCTACT 1080 AGTTGCTCAA GGCCCAAGCA AAGAGAAGGC AAAGGGTCGG AGTAGGAGGC AACAAGAAAA 1140 CCACAAATGT GAACTTACCA AAAAAAAGTG ACAGGAAGAA AAATTAAAGA AACTTGTGGT 1200 TAAAAAAAAT AAAGACACAA TCTTTGACAG AGAAAGCAGC AGGAGGTGGC AAACTTGAAT 1260 GCTCACAAGG GCTAATACCT AAGCTAAATG AATGAACTTG AGCAAGATGT GACAATAGGT 1320 AGTGGTGGGG ACTATGACAA ACTAGAAGAT GTATTTAAAG GTATTCCTAT TCAGCTTTTA 1380 AAAAGTAGAC ATCACAGGCC AAATAAGCCA CAGGTCTCTA TTTTTTATCC TCTGGGTGTA 1440 GAGAAACAAT GGTAGTGGCA ATGGTAAAAT ATATCATTGC TACCTGCCCA CTGGGGATGA 1500 GGCTGGCCAG CCAAGAATGT TTTTAAACAA ACTTATCTTA ATGACAAAAA GCTGCAAGTA 1560 AGACTAATTG CTTTATAATC TTATTACACT GTTATATGAC TATTATGATT CATAATTCAA 1620 GCATGAGATC TGCTGCTTCT CTCCATCACA AAACCAAAAT ACTATGTTCA TGGATGATTA 1680 AGATTGACTT ATTGGCTTAA TGTGATACAA ATCCTGCCAG TATGACCCCC AAAGGCGTAT 1740 TTCACACTCA TAGTGGGTCT CTGAGGTAGT TATTAATGTA TAAAAGTTCC AAGGTCTCCC 1800 AGGGACATAG ATCTTTATCC TGAGAAGTAC TTGTAACTGA CATTCTAAAT GTTCCCTTAC 1860 ATGTGTATTA TATCATGATA AGAGGTTTTT GCTTTTGTTT TTATTGCCAC TTAGTTTTGA 1920 TCAAAACATT CCTCCTTTTT GCATCCCTGT TAACTGAAAA ATGACAGTCT TGTGGACCTG 1980 AAAGATCATT CTTCTGAAAG ATGGGACCAA ATTCAATTAG ATATCAACAT TGTAATCAGC 2040 TCTGTTTAGC 2050
|